The Valley Desk

NCT05524883 · Interventional trial

Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Duchenne Muscular Dystrophy (DMD)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov